Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Junrong Gao"'
Autor:
Abin You, Manqing Cao, Zhigui Guo, Bingfeng Zuo, Junrong Gao, Hongyuan Zhou, Huikai Li, Yunlong Cui, Feng Fang, Wei Zhang, Tianqiang Song, Qiang Li, Xiaolin Zhu, Haifang Yin, Huichuan Sun, Ti Zhang
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-9 (2016)
Abstract Background Sorafenib is recognized as a standard treatment for advanced hepatocellular carcinoma (HCC). However, many patients have to adopt dose reduction or terminate the use of sorafenib because of side effects. In addition, a large numbe
Externí odkaz:
https://doaj.org/article/9b898ac78eaf43a5afab3ddebfc71071
Publikováno v:
Mathematical Methods in the Applied Sciences. 44:5475-5500
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e2f3b2ec6cb596fd6c93fad970d331b
https://doi.org/10.1002/mma.7123
https://doi.org/10.1002/mma.7123
Autor:
Huikai Li, Junrong Gao, Qiang Li, Hui-Chuan Sun, Zhigui Guo, Feng Fang, A-Bin You, Tianqiang Song, Ti Zhang, Man-Qing Cao, Hongyuan Zhou, Xiaolin Zhu, Yunlong Cui, Wei Zhang
Publikováno v:
Cancer Science
We previously found that a low dose of sorafenib had a prometastatic effect on hepatocellular carcinoma (HCC), which was caused by downregulation of TIP30 expression. More recently, metformin has been shown to have potential as a preventive and thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8104c369edf8c0db3da20423540f04c
http://europepmc.org/articles/PMC4832852
http://europepmc.org/articles/PMC4832852
Autor:
Manqing Cao, Wei Zhang, Ti Zhang, Hongyuan Zhou, Zhigui Guo, A-Bin You, Feng Fang, Junrong Gao, Jiafei Huang, Tianqiang Song
Publikováno v:
Tumor Biology. 37:1651-1662
Overexpression of CUB domain-containing protein 1 (CDCP1), a transmembrane glycoprotein and major substrate of Src family kinases (SFKs), always indicates unfavorable outcomes in various cancers. The characteristics of CDCP1 in hepatocellular carcino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6febbfb27f1238e4b4da9ded3c3d6609
https://doi.org/10.1007/s13277-015-3527-7
https://doi.org/10.1007/s13277-015-3527-7
Autor:
A-Bin You, Hongyuan Zhou, Xiaolin Zhu, Wei Zhang, Tianqiang Song, Ti Zhang, Huikai Li, Bingfeng Zuo, Qiang Li, Yunlong Cui, Hui-Chuan Sun, Junrong Gao, Zhigui Guo, Man-Qing Cao, Haifang Yin, Feng Fang
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-9 (2016)
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-9 (2016)
Background Sorafenib is recognized as a standard treatment for advanced hepatocellular carcinoma (HCC). However, many patients have to adopt dose reduction or terminate the use of sorafenib because of side effects. In addition, a large number of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::610ae53b8328e91de18931dcf447e45b
http://europepmc.org/articles/PMC4784359
http://europepmc.org/articles/PMC4784359
Autor:
Abin You, Manqing Cao, Zhigui Guo, Bingfeng Zuo, Junrong Gao, Hongyuan Zhou, Huikai Li, Yunlong Cui, Fang, Feng, Zhang, Wei, Tianqiang Song, Li, Qiang, Xiaolin Zhu, Haifang Yin, Huichuan Sun, Zhang, Ti
TIP30 was regulated by HIF-2Îą at protein level in Hep3B. (DOCX 66.9 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::187dc8af0c6327f6a53b24b2f46b5b56
Autor:
Abin You, Manqing Cao, Zhigui Guo, Bingfeng Zuo, Junrong Gao, Hongyuan Zhou, Huikai Li, Yunlong Cui, Fang, Feng, Zhang, Wei, Tianqiang Song, Li, Qiang, Xiaolin Zhu, Haifang Yin, Huichuan Sun, Zhang, Ti
Knocking-down of HIF-2Îą decreased the expression levels of EGFR and its associated downstream molecules by upregulating TIP30 expression. (DOCX 55.5 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::176bef692501b820eca70f55d9a78139